Duopharma Biotech Berhad which has been authorised to distribute Sinopharm vaccines in the country has finally gotten the batches into clinic and private hospital shelves.
Since receiving conditional approval from the Ministry of Health’s Drug Control Authority (DCA) in July, Duopharma has seen its first shipment arrive and is now widely available in shipped in clinics and private hospitals nationwide. With a shelf life of 24 months, it is appropriate for longer term vaccination efforts. Additionally, the Sinopharm vaccine is a convenient single dose per vial of 0.5mL, which helps to prevent wastage and is easy for planning vaccine administration. The vaccine’s cold chain storage is also straightforward and easy, at a standard conventional storage temperature of 2°C to 8°C.
Administration of the vaccine is fully integrated into the national immunisation system, where the vaccines are tracked based on the Vaccine Management System provided by the Ministry of Health, with real-time integration of both MyVAS and the MySejahtera app. Vaccinees receiving their first and second doses will immediately have these recorded on their MySejahtera accounts, and will also receive their digital certificate accordingly.
For vaccination of large groups, such as the workforce in manufacturing facilities, Duopharma Biotech, via collaboration with healthcare organisers, provides private vaccination services as well as mobile vaccine clinics, which is supported by a team of medical professionals, paramedics, site managers and an operations and administration team.
